Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c00871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Alexander Engstrom und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, Santa Cruz, 1156 High St., Santa Cruz, California 95064, United States. Hauptthemen laut MEDLINE: Cell Membrane Permeability, Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Membrane permeability is critical to the function of proteolysis targeting chimeras (PROTACs), yet common methods such as the parallel artificial membrane permeability assay (PAMPA) and Caco-2 transwell assays are limited by their experimental configuration and fail to directly measure a compound's ability to access the cytosolic space of a target cell. Here, we present a method to measure the membrane permeability of unmodified PROTACs and other E3 ligase ligands directly into the cytosol of living cells. By utilizing NanoBRET live-cell target engagement in real time, we quantify permeability rates that match those from transwell systems and reveal rates that transwell setups fail to measure. Several previously undetectable BET-targeting PROTACs, with subtle structural changes, display differing permeabilities that rationalize discrepancies in live-cell degradation efficiency and cytotoxicity. Ultimately, this approach enables quantitative permeability profiling of PROTACs previously considered unmeasurable in transwell assays, providing a powerful tool to guide rational design and lead optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California, Santa Cruz, 1156 High St., Santa Cruz, California 95064, United States.
- Promega Corporation, 2800 Woods Hollow Road, Madison, Wisconsin 53711, United States.
ORCID-Profile: Alexander Engstrom, R Scott Lokey
Förderung
- National Institutes of Health
Zitieren
APA
Engstrom, A., Vasta, J. D., Robers, M. B., & Lokey, R. S. (2026). Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00871
Vancouver
Engstrom A, Vasta JD, Robers MB, Lokey RS. Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00871
BibTeX
@article{Engstrom2026,
author = {Engstrom, Alexander and Vasta, James D and Robers, Matthew B and Lokey, R Scott},
title = {Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c00871}
}
EUVIMED